Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Carolina Urologic Research Center has participated in nearly 500 national and international clinical research trials since its founding in 1998. It is recognized as one of the most respected urologic oncology research sites globally, with expertise spanning prostate, bladder, and renal cancers as well as other urological conditions. The center was acquired by the START Center for Cancer Research in March 2025 to expand genitourinary oncology trial capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Carolina Urologic Research Center.